Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980;71(1):169–175. doi: 10.1111/j.1476-5381.1980.tb10922.x

Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol.

A Bennett, C Jarosik, G J Sanger, D E Wilson
PMCID: PMC2044421  PMID: 6110453

Abstract

1 The effects of SC-19220, sodium meclofenamate, indomethacin or trimethoquinol were studied on contractions of the rat stomach longitudinal muscle to prostaglandin D2 (PGD2), PGE2, PGF2 alpha, PGH2, epoxymethano PGH2 analogues, PGI2, 6-keto-PGF1 alpha, 6,15-diketo-PGF1 alpha and thromboxane B2. All the drugs reduced contractions to all the prostanoids, but the degree of reduction differed widely. Selectivity of blockade was assessed by comparison with acetylcholine (ACh). 2 With SC-19220 5 micrograms/ml the effect on thromboxane B2, PGD2 or PGH2 and its epoxymethano analogues was not significantly different from the small effect on ACh, but the other prostanoids were blocked to greater extents. 3 The effect of the cyclo-oxygenase inhibitor sodium meclofenamate, 1 or 2 micrograms/ml, on 6,15-diketo-PGF1 alpha or thromboxane B2 was similar to the small antagonism of ACh, whereas the other prostanoids were blocked to greater extents. Indomethacin, 1 microgram/ml, also reduced contractions to the prostanoids, but antagonism of the PGH2 epoxymethano analogues was considerably less than with meclofenamate. 4 The beta-adrenoceptor stimulant trimethoquinol, 50 ng/ml, was the most potent prostanoid antagonist tested; all the prostanoids except PGE2 were antagonized more than ACh.

Full text

PDF
169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett A., Carroll M. A., Sanger G. J. Sodium flufenamate antagonises the potentiation by prostaglandins of noradrenaline-induced vasoconstriction in rat mesentery [proceedings]. Br J Pharmacol. 1979 Jul;66(3):449P–449P. [PMC free article] [PubMed] [Google Scholar]
  2. Bennett A., Jarosik C., Wilson D. E. A study of receptors activated by analogues of prostaglandin H2 [proceedings]. Br J Pharmacol. 1978 Jun;63(2):358P–358P. [PMC free article] [PubMed] [Google Scholar]
  3. Bennett A., Posner J. Studies on prostaglandin antagonists. Br J Pharmacol. 1971 Aug;42(4):584–594. doi: 10.1111/j.1476-5381.1971.tb07142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bennett A., Pratt D., Sanger G. J. Antagonism by fenamates of prostaglandin action in guinea-pig and human alimentary muscle. Br J Pharmacol. 1980 Mar;68(3):357–362. doi: 10.1111/j.1476-5381.1980.tb14548.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bennett A., Sanger G. J. The effects of prostaglandin D2 on the circular muscle of guinea-pig isolated ileum and colon [proceedings]. Br J Pharmacol. 1978 Jun;63(2):357P–358P. [PMC free article] [PubMed] [Google Scholar]
  6. Bennett A., Sanger G. J. Trimethoquinol selectively antagonises longitudinal muscle contractions of rat isolated gastric fundus to thromboxane B2 and epoxymethano analogues of PGH2 [proceedings]. Br J Pharmacol. 1979 Jul;66(3):450P–450P. [PMC free article] [PubMed] [Google Scholar]
  7. Bunting S., Moncada S., Vane J. R. The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings]. Br J Pharmacol. 1976 Jul;57(3):462P–463P. [PMC free article] [PubMed] [Google Scholar]
  8. Coceani F., Wolfe L. S. On the action of prostaglandin E1 and prostaglandins from brain on the isolated rat stomach. Can J Physiol Pharmacol. 1966 Nov;44(6):933–950. doi: 10.1139/y66-116. [DOI] [PubMed] [Google Scholar]
  9. Coleman R. A., Humphrey P. P., Kennedy I., Levy G. P., Lumley P. U-46619, a selective thromboxane A2-like agonist? [proceedings]. Br J Pharmacol. 1980 Jan;68(1):127P–128P. [PMC free article] [PubMed] [Google Scholar]
  10. Famaey J. P., Fontaine J., Reuse J. Effect of high concentrations of non-steroidal and steroidal antiinflammatory drugs on prostaglandin-induced contractions of the guinea-pig isolated ileum. Prostaglandins. 1977 Jan;13(1):107–114. doi: 10.1016/0090-6980(77)90047-8. [DOI] [PubMed] [Google Scholar]
  11. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  12. Gardiner P. J., Collier H. O. Specific receptors for prostaglandins in airways. Prostaglandins. 1980 Jun;19(6):819–841. doi: 10.1016/0090-6980(80)90116-1. [DOI] [PubMed] [Google Scholar]
  13. Hamberg M., Hedqvist P., Strandberg K., Svensson J., Samuelsson B. Prostaglandin endoperoxides IV. Effects on smooth muscle. Life Sci. 1975 Feb 1;16(3):451–462. doi: 10.1016/0024-3205(75)90266-0. [DOI] [PubMed] [Google Scholar]
  14. Hanna C. J., Eyre P. Effects of trimetaquinol on equine pulmonary vascular and airway smooth muscle. J Pharm Pharmacol. 1979 Dec;31(12):858–859. doi: 10.1111/j.2042-7158.1979.tb13682.x. [DOI] [PubMed] [Google Scholar]
  15. Hong E. Differential pattern of activity of some prostaglandins in diverse superfused tissues. Prostaglandins. 1974 Nov 10;8(3):213–220. doi: 10.1016/0090-6980(74)90044-6. [DOI] [PubMed] [Google Scholar]
  16. Horton E. W., Jones R. L. Prostaglandins A1,A2 and 19-hydroxy A1; their actions on smooth muscle and their inactivation on passage through the pulmonary and hepatic portal vascular beds. Br J Pharmacol. 1969 Nov;37(3):705–722. doi: 10.1111/j.1476-5381.1969.tb08509.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lembeck F., Juan H. Interaction of prostaglandins and indomethacin with algesic substances. Naunyn Schmiedebergs Arch Pharmacol. 1974;285(4):301–313. doi: 10.1007/BF00501460. [DOI] [PubMed] [Google Scholar]
  18. Malmsten C. Some biological effects of prostaglandin endoperoxide analogs. Life Sci. 1976 Jan 15;18(2):169–176. doi: 10.1016/0024-3205(76)90021-7. [DOI] [PubMed] [Google Scholar]
  19. Northover B. J. Effect of anti-inflammatory drugs on the binding of calcium to cellular membranes in various human and guinea-pig tissues. Br J Pharmacol. 1973 Jul;48(3):496–504. doi: 10.1111/j.1476-5381.1973.tb08356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Omini C., Moncada S., Vane J. R. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S). Prostaglandins. 1977 Oct;14(4):625–632. doi: 10.1016/0090-6980(77)90189-7. [DOI] [PubMed] [Google Scholar]
  21. Sanger G. J., Bennett A. Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium. Br J Clin Pharmacol. 1979 Nov;8(5):479–482. doi: 10.1111/j.1365-2125.1979.tb01030.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sanner J. H. Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220). Arch Int Pharmacodyn Ther. 1969 Jul;180(1):46–56. [PubMed] [Google Scholar]
  23. Sorrentino L., Capasso F., Di Rosa M. Indomethacin and prostaglandins. Eur J Pharmacol. 1972 Feb;17(2):306–308. doi: 10.1016/0014-2999(72)90177-x. [DOI] [PubMed] [Google Scholar]
  24. Splawinski J. A., Nies A. S., Sweetman B., Oates J. A. The effects of arachidonic acid, prostaglandin E2 and prostaglandin F2alpha on the longitudinal stomach strip of the rat. J Pharmacol Exp Ther. 1973 Dec;187(3):501–510. [PubMed] [Google Scholar]
  25. Tolman E. L., Partridge R. Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents. Prostaglandins. 1975 Mar;9(3):349–359. doi: 10.1016/0090-6980(75)90139-2. [DOI] [PubMed] [Google Scholar]
  26. Whittle B. J., Mugridge K. G., Moncada S. Use of the rabbit transverse stomach-strip to identify and assay prostacyclin, PGA2, PGD2 and other prostaglandins. Eur J Pharmacol. 1979 Jan 1;53(2):167–172. doi: 10.1016/0014-2999(79)90162-6. [DOI] [PubMed] [Google Scholar]
  27. Yamamura Y., Kishimoto S. Clinical effectiveness of a new bronchodilator, inolin, on bronchial asthma. Ann Allergy. 1968 Sep;26(9):504–507. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES